A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2024-04-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the absorption, metabolism, and elimination of
CC-90010 and its metabolites following a single oral dose of radiolabeled CC-90010 in
participants with advanced solid tumors.